Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
In Vivo (Athens, Greece)|December 29, 2015
CpG-Oligodeoxynucleotides in Chronic Rhinosinusitis Cell CultureRichard Birk, Christoph Aderhold, Karl Hörmann, et al.
Sleep & Breathing = Schlaf & Atmung|December 31, 2021
Sleep position, patient comfort, and technical performance with two established procedures for home sleep testingC Emika Mueller, Hansen Li, Sophia M Begasse, et al.
Anticancer Research|September 10, 2014
Matrix metalloproteinase-2 and -14 in p16-positive and -negative HNSCC after exposure To 5-FU and docetaxel In VitroChristoph Aderhold, Claudia Umbreit, Anne Faber, et al.
In Vivo (Athens, Greece)|July 2, 2014
Anti-inflammatory effects of polihexanide and polyethylene glycol in an in vitro study in chronic rhinosinusitisRichard Birk, Judith Grossbaier, Christoph Aderhold, et al.
Experimental and Therapeutic Medicine|August 18, 2022
An <i>in vitro</i> study on the effect of bevacizumab on endothelial cell proliferation and VEGF concentration level in patients with hereditary hemorrhagic telangiectasiaHaneen Sadick, Elena Schäfer, Christel Weiss, et al.
Anticancer Research|May 29, 2017
Impact of Small Molecules on β-Catenin and E-Cadherin Expression in HPV16-positive and -negative Squamous Cell CarcinomasBenedikt Kramer, Clemens Hock, Johannes David Schultz, et al.
Anticancer Research|July 5, 2022
Targeted Treatment of HPV16-positive and -negative SCC Cells With Small Molecule Tyrosine Kinase Inhibitors and Everolimus Affects MMP2 and MMP14 ExpressionLena Huber, Richard Birk, Manuel Knuettel, et al.
Cancer Genomics & Proteomics|August 30, 2020
Expression Patterns of CD44 and AREG Under Treatment With Selective Tyrosine Kinase Inhibitors in HPV<sup>+</sup> and HPV<sup>-</sup> Squamous Cell CarcinomaBenjamin Kansy, Christoph Aderhold, Lena Huber, et al.
Anticancer Research|June 9, 2016
Targeted Therapies in HPV-positive and -negative HNSCC - Alteration of EGFR and VEGFR-2 Expression In VitroBenedikt Kramer, Clemens Hock, Richard Birk, et al.
Anticancer Research|April 12, 2015
Targeting mTOR and AREG with everolimus, sunitinib and sorafenib in HPV-positive and -negative SCCChristoph Aderhold, Anne Faber, Claudia Umbreit, et al.
Pageof 5